Performance Overview for the Quarter Ending June 30, 2026
The Group achieved a revenue total of Rs. 28.77 billion during the first quarter of FY27, marking a year-on-year increase of 0.9%. The gross profit margin saw a slight enhancement, rising by 0.2 percentage points to reach 30.4%. However, EBITDA experienced a significant decline of 14.1%, amounting to Rs. 2.26 billion, while earnings attributable to equity holders fell by 21.4% to Rs. 937 million. Revenue growth in the Consumer Brands, Hospitals, and Mobility sectors was counterbalanced by a 3.8% decrease in the Life Sciences segment. This discrepancy between revenue growth and earnings was mainly due to a rapid increase in costs that could not be promptly addressed through pricing adjustments.
The quarter was influenced by increased geopolitical tensions resulting from escalating conflicts in the Middle East, which drove up costs for fuel, petroleum-based raw materials, freight, and insurance. In Sri Lanka, prices for petrol and diesel surged over 40% year-on-year, while the Sri Lankan Rupee (LKR) depreciated, averaging an 8% decline year-on-year and 5% quarter-on-quarter. Average inflation, recorded at 5.9% and peaking at 6.8% in June, further dampened consumption growth and raised both direct and indirect operational costs.
Although pricing strategies and product mix contributed positively to the gross profit margin, net operating costs rose by 9% compared to the previous year. Selling and distribution expenses escalated by 12.3%, constituting over half of the total increase in operating costs, largely due to heightened logistics, fuel, freight, and distribution expenses. In certain Consumer Brands categories, price increases were strategically implemented to maintain sales volumes, as it was anticipated that cost pressures would be temporary. Consequently, the Group absorbed some of these cost hikes during the quarter. In the Life Sciences sector, the situation was more challenging due to regulated pharmaceutical prices; thus, price adjustments did not immediately account for the LKR depreciation and increased import costs, leading to a delay in cost recovery until regulatory approvals were secured. Moreover, the depreciation of the LKR heightened finance costs for the Leisure Joint Venture related to its USD borrowings, adversely impacting the Group’s earnings.
Despite these challenges, robust earnings growth in the Mobility sector and increased finance income from the Group’s net cash position helped mitigate some of the adverse impacts. The continuity of supply was maintained throughout the quarter, albeit at a higher cost. Management’s immediate focus is on recovering costs, ensuring volume protection through strategic pricing, boosting productivity initiatives, and enhancing profitability in both Consumer Brands and Life Sciences. While volatility in energy prices and currency values is anticipated to continue, the Group is dedicated to strengthening its performance and pursuing long-term growth objectives with diligence.
Financial and Operational Insights
Revamped Reporting Framework
Looking ahead, the Group will reorganize its segmental reporting into four main categories: Consumer Brands, Life Sciences, Hospitals, and Mobility. A significant change involves the division of the previous Healthcare segment into two separate categories—Hospitals and Life Sciences—highlighting the distinct differences in management and operations of these businesses.
The principal distinction lies in the nature of the operations: Hospitals are service-oriented, while pharmaceutical distribution and manufacturing focus on products. The Hospitals segment is characterized by a labor-intensive and asset-heavy model, which typically has a longer payback period compared to pharmaceutical distribution and manufacturing. These fundamental differences necessitate varied capital allocation strategies, margin considerations, and growth factors, prompting the restructured reporting framework to better align with management’s perspective on these business units. This adjustment is in line with the Group’s commitment to enhancing transparency and providing shareholders with a clearer understanding of the business’s performance.
Financial Chronicle Biz English | Sri Lanka Business News.
